Last reviewed · How we verify
Smoking Cessation Interventions for People Living With HIV in Nairobi, Kenya
The proposed study will use a factorial design to evaluate the most promising and accessible behavioral and pharmacologic treatments aimed at achieving maximal efficacy for smoking cessation among people living with HIV who smoke. The study will randomize 300 participants people living with HIV , who smoke and who are receiving care in HIV clinics affiliated with the Center for International Health, Education, and Biosecurity in Nairobi, Kenya to one of the following 4 conditions: (1) bupropion + Positively Smoke Free (an 8 session tailored behavioral intervention for people living with HIV smokers); (2) bupropion + Standard of Care (brief advice to quit); (3) Placebo + Positively Smoke Free; and (4) Placebo + Standard of Care.
Details
| Lead sponsor | University of Maryland, Baltimore |
|---|---|
| Phase | PHASE3 |
| Status | COMPLETED |
| Enrolment | 300 |
| Start date | Sat Aug 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Tue Jul 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- HIV
- Smoking Cessation
Interventions
- Bupropion
- Positively smoke free
- Brief advice to quit smoking
Countries
Kenya